Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice-Reference-Cited by-同舟云学术

Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice

Published:2012 Issue:1 Volume:120 Page:36-44
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Tahara Atsuo,Kurosaki Eiji,Yokono Masanori,Yamajuku Daisuke,Kihara Rumi,Hayashizaki Yuka,Takasu Toshiyuki,Imamura Masakazu,Qun Li,Tomiyama Hiroshi,Kobayashi Yoshinori,Noda Atsushi,Sasamata Masao,Shibasaki Masayuki

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference29 articles.

1. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance

2. 2 Idris I, Donnelly R. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug. Diabetes Obes Metab. 2009;11:79–88.

3. 3 Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510–518.

4. 4 Pajor AM, Wright EM. Cloning and functional expression of a mammalian Na+/nucleoside cotransporter. A member of the SGLT family. J Biol Chem. 1992;267:3557–3560.

5. Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats;American Journal of Physiology-Renal Physiology;2022-09-01

2. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model;PLOS ONE;2022-02-22

3. Peripheral combination treatment of leptin and an SGLT2 inhibitor improved glucose metabolism in insulin-dependent diabetes mellitus mice;Journal of Pharmacological Sciences;2021-12

4. Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway;Diabetes & Metabolism Journal;2021-11-30

5. Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume;Physiological Reports;2020-01